Skip to main content
Clinical Trials/IRCT20180126038510N1
IRCT20180126038510N1Not yet recruitingPhase 3

Assessment of topical Palm date (Phoenix dactylifera L.) product on clinical manifestation of knee Osteoarthritis versus Diclofenac gel: A randomized clinical trial

Tabriz University of Medical Sciences0 sites94 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
94

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40 years to 70 years (—)
Sex
All

Inclusion Criteria

  • Mild to moderate knee Ostoarthritis patients according to Kellegren-Lawrence (K-L) grading scale
  • Pain at least in one knee in last 3 month ago
  • Minimum annoying pain in last (at least ) 4 week before randomized selection according to VAS scale

Exclusion Criteria

  • Allergy to topical preparation of Date palm and Diclofenac gel
  • Skin lesion on the knee
  • Secondary Osteoarthritis as Rhuomatoid arthritis,Gout,Infectious arthritis,Metabolic arthritis,Traumatic arthritis
  • Operative knee joint replacement
  • Topical or systemic steroid use since 14 day before study
  • Intraarticular steroid injection since 90 day before study
  • Pregnancy and lactation period
  • Alcohol and opioid addiction
  • Radiculopathy and Neuropathy
  • History of any kind of knee operation and trauma
  • Utilization of other analgesic drugs since study period
  • Nonconformity of life style according to knee health

Investigators

Similar Trials